Current NDC auxiliary source row compounder:567

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5558
Product Ndc: 26436-5558
Product Ndc Digits: 264365558
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: NAD
Proprietary Name Suffix: [empty]
Nonproprietary Name: NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: NADIDE
Active Ingredients Info: 50 mg/1 mL
History Active Ingredients Raw: NADIDE
History Active Ingredients Info Raw: 50 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 26436-5558-0
Package Ndc: 26436-5558-0
Package Ndc Digits: 2643655580
Package Ndc11: 26436555800
Package Description: 10 mL in 1 VIAL (26436-5558-0)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:567
Source Row Number: 567
Source Row Hash: 43c0ac59fbcc86c9888051e0e56fd29d841ee0e621747d6de174431b96559700
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "26436-5558",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "NADIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "26436-5558-0",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "NAD",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg",
    "PACKAGEDESCRIPTION": "10 mL in 1 VIAL (26436-5558-0) ",
    "ACTIVEINGREDIENTSINFO": "50 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:567
Source Row Number: 567
Status Scope: package
Lookup Ndc: 26436-5558-0
Lookup Ndc Digits: 2643655580
Product Ndc: 26436-5558
Product Ndc Digits: 264365558
Package Ndc: 26436-5558-0
Package Ndc Digits: 2643655580
Package Ndc11: 26436555800
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 43c0ac59fbcc86c9888051e0e56fd29d841ee0e621747d6de174431b96559700
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51